In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.

Jevitt, Laura A; Smith, Amanda J; Williams, Portia P; Raney, Patti M; McGowan, John E; Tenover, Fred C

Jevitt, Laura A; Smith, Amanda J; Williams, Portia P; Raney, Patti M; McGowan, John E; Tenover, Fred C.

Affiliation

Jevitt LA; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. lgj9@cdc.gov

Microb Drug Resist ; 9(4): 389-93, 2003.

Article in En | MEDLINE | ID: mdl-15000746

Subject(s)

Acetamides/pharmacology; Anti-Bacterial Agents/pharmacology; Anti-Infective Agents/pharmacology; Daptomycin/pharmacology; Drug Therapy, Combination/pharmacology; Enterococcus faecium/drug effects; Oxazolidinones/pharmacology; Staphylococcus aureus/drug effects; Vancomycin Resistance; Virginiamycin/pharmacology; Genes, Bacterial/genetics; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus/genetics; Vancomycin Resistance/genetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcus aureus / Virginiamycin / Enterococcus faecium / Daptomycin / Vancomycin Resistance / Oxazolidinones / Drug Therapy, Combination / Acetamides / Anti-Infective Agents / Anti-Bacterial Agents Language: En Journal: Microb Drug Resist Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links